Cargando…

Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya

BACKGROUND: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. METHOD: A 5-year (2012–2016) retrospective analysis of electr...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullahi, Osman A., Ngari, Moses M., Sanga, Deche, Katana, Geoffrey, Willetts, Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622488/
https://www.ncbi.nlm.nih.gov/pubmed/31295277
http://dx.doi.org/10.1371/journal.pone.0219191
_version_ 1783434164939259904
author Abdullahi, Osman A.
Ngari, Moses M.
Sanga, Deche
Katana, Geoffrey
Willetts, Annie
author_facet Abdullahi, Osman A.
Ngari, Moses M.
Sanga, Deche
Katana, Geoffrey
Willetts, Annie
author_sort Abdullahi, Osman A.
collection PubMed
description BACKGROUND: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. METHOD: A 5-year (2012–2016) retrospective analysis of electronic TB surveillance data from Kilifi County, Kenya. The outcome was all-cause mortality within 180 days after starting TB treatment. The risk factors examined were demographic and clinical features at the time of starting anti-TB treatment. We performed survival analysis with time at risk defined from day of starting TB treatment to time of death, lost-to-follow-up or completing treatment. To account for ‘lost-to-follow-up’ we used competing risk analysis method to examine risk factors for all-cause mortality. RESULTS: 10,717 patients receiving TB treatment, median (IQR) age 33 (24–45) years were analyzed; 3,163 (30%) were HIV infected. Overall, 585 (5.5%) patients died; mortality rate of 12.2 (95% CI 11.3–13.3) deaths per 100 person-years (PY). Mortality rate increased from 7.8 (95% CI 6.4–9.5) in 2012 to 17.7 (95% CI 14.9–21.1) in 2016 per 100PY (P(trend)<0.0001). 449/585 (77%) of the deaths occurred within the first three months after starting TB treatment. The median time to death (IQR) declined from 87 (40–100) days in 2012 to 46 (18–83) days in 2016 (P(trend) = 0·04). Mortality rate per 100PY was 7.3 (95% CI 6.5–7.8) and 23.1 (95% CI 20.8–25.7) among HIV-uninfected and HIV-infected patients respectively. Age, being a female, extrapulmonary TB, being undernourished, HIV infected and year of diagnosis were significantly associated with mortality. CONCLUSIONS: We found most deaths occurred within three months and an increasing mortality rate during the time under review among patients on TB treatment. Our results therefore warrant further investigation to explore host, disease or health system factors that may explain this trend.
format Online
Article
Text
id pubmed-6622488
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66224882019-07-25 Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya Abdullahi, Osman A. Ngari, Moses M. Sanga, Deche Katana, Geoffrey Willetts, Annie PLoS One Research Article BACKGROUND: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation. METHOD: A 5-year (2012–2016) retrospective analysis of electronic TB surveillance data from Kilifi County, Kenya. The outcome was all-cause mortality within 180 days after starting TB treatment. The risk factors examined were demographic and clinical features at the time of starting anti-TB treatment. We performed survival analysis with time at risk defined from day of starting TB treatment to time of death, lost-to-follow-up or completing treatment. To account for ‘lost-to-follow-up’ we used competing risk analysis method to examine risk factors for all-cause mortality. RESULTS: 10,717 patients receiving TB treatment, median (IQR) age 33 (24–45) years were analyzed; 3,163 (30%) were HIV infected. Overall, 585 (5.5%) patients died; mortality rate of 12.2 (95% CI 11.3–13.3) deaths per 100 person-years (PY). Mortality rate increased from 7.8 (95% CI 6.4–9.5) in 2012 to 17.7 (95% CI 14.9–21.1) in 2016 per 100PY (P(trend)<0.0001). 449/585 (77%) of the deaths occurred within the first three months after starting TB treatment. The median time to death (IQR) declined from 87 (40–100) days in 2012 to 46 (18–83) days in 2016 (P(trend) = 0·04). Mortality rate per 100PY was 7.3 (95% CI 6.5–7.8) and 23.1 (95% CI 20.8–25.7) among HIV-uninfected and HIV-infected patients respectively. Age, being a female, extrapulmonary TB, being undernourished, HIV infected and year of diagnosis were significantly associated with mortality. CONCLUSIONS: We found most deaths occurred within three months and an increasing mortality rate during the time under review among patients on TB treatment. Our results therefore warrant further investigation to explore host, disease or health system factors that may explain this trend. Public Library of Science 2019-07-11 /pmc/articles/PMC6622488/ /pubmed/31295277 http://dx.doi.org/10.1371/journal.pone.0219191 Text en © 2019 Abdullahi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abdullahi, Osman A.
Ngari, Moses M.
Sanga, Deche
Katana, Geoffrey
Willetts, Annie
Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
title Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
title_full Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
title_fullStr Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
title_full_unstemmed Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
title_short Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya
title_sort mortality during treatment for tuberculosis; a review of surveillance data in a rural county in kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622488/
https://www.ncbi.nlm.nih.gov/pubmed/31295277
http://dx.doi.org/10.1371/journal.pone.0219191
work_keys_str_mv AT abdullahiosmana mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya
AT ngarimosesm mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya
AT sangadeche mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya
AT katanageoffrey mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya
AT willettsannie mortalityduringtreatmentfortuberculosisareviewofsurveillancedatainaruralcountyinkenya